Cannabix Technologies (BLO.CN), developer of marijuana and alcohol breath devices, deployed its BreathLogix alcohol screening technology with mining, municipal, and aviation clients in Australia, under terms of an agreement with its exclusive distribution partner in that country, it said on Friday.
The BreathLogix device rapidly screens for alcohol using a breath sample while simultaneously capturing a photograph of the user to support identity verification, Friday's statement noted.
Shares closed down 7.1% to $0.65 on Thursday on the Canadian Securities Exchange.
Price: $0.65, Change: $-0.05, Percent Change: -7.14%